HOC people: Patti Peeples Gustafson, PhD
By David Woods ([email protected]) Dr. Patti Peeples: what a perfect name for the subject of HOC people! She tells me that the origin of the name is from Peebles, in…
Details
Develop a healthy scepticism about research even in the ‘best’ scientific journals
By David Woods ([email protected]) The Wall Street Journal published an editorial last month titled “The Lancet’s Political Hit.” It described how that venerable medical journal had published a study exaggerating…
Details
The importance of the economic value message
The pharmaceutical industry faces the major issue of top selling drugs losing their patent protection, allowing generic products to replace them at much lower prices.
Details
Dealing with the media – confidently
By Julie Stauffer ([email protected]) The media can be a powerful vehicle for raising your profile, getting your message out and gaining credibility, but not everyone feels comfortable confronting a reporter’s…
Details
Is big pharma becoming big biotech?
Recent reports in the Wall Street Journal and The Economist describe an imminent seismic shift in business models for pharmaceutical companies, as current blockbuster drugs are set to go off-patent and a rapidly dwindling pipeline of new drugs are under development or are being reviewed for approval.
Details
How to be a more effective public speaker
By Mary Gabb ([email protected]) A frequently overlooked professional skill – especially among scientists – is public speaking, yet the inability to effectively communicate your work can place significant roadblocks in…
Details
Wiring healthcare
By David Woods ([email protected]) A pair of economists, Charles Jones of the University of California at Berkeley and Robert Hall of Stanford University, predict that the share of income devoted…
Details
A new way for pharmaceutical companies and prescribers to interact?
By David Woods ([email protected]) Call them Sermoans, Sermophiles, or just plain members, the 32,000 physicians enrolled in Sermo could be changing the way that pharmaceutical companies interact with healthcare professionals.…
Details
You need to know the global issues in health economics
By Robert Hand ([email protected]) As a health economist and outcomes researcher, you may work primarily within a single country. Naturally, you know the economic, regulatory, and management issues of that…
Details
What is the value of outcomes research?
By Kevin Frick ([email protected]) It is ironic that we should have to answer the question: “what is the value of outcomes research?” when outcomes research is a key component of…
Details